34,698 Shares in Clarivate Plc (NYSE:CLVT) Purchased by AXQ Capital LP

AXQ Capital LP bought a new position in shares of Clarivate Plc (NYSE:CLVT – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 34,698 shares of the company’s stock, valued at approximately $289,000.

Several other hedge funds and other institutional investors have also modified their holdings of CLVT. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Clarivate by 3.9% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 143,922 shares of the company’s stock valued at $1,351,000 after purchasing an additional 5,379 shares during the period. National Bank of Canada FI boosted its holdings in Clarivate by 95.9% in the 4th quarter. National Bank of Canada FI now owns 1,765,885 shares of the company’s stock valued at $14,727,000 after purchasing an additional 864,508 shares during the period. Barclays PLC boosted its holdings in Clarivate by 56.6% in the 3rd quarter. Barclays PLC now owns 330,471 shares of the company’s stock valued at $3,104,000 after purchasing an additional 119,507 shares during the period. Alpha Paradigm Partners LLC bought a new stake in Clarivate in the 3rd quarter valued at about $667,000. Finally, Allstate Corp boosted its holdings in Clarivate by 113.4% in the 3rd quarter. Allstate Corp now owns 54,365 shares of the company’s stock valued at $510,000 after purchasing an additional 28,889 shares during the period. Institutional investors own 87.34% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on CLVT shares. Royal Bank of Canada restated an “outperform” rating and issued a $14.00 target price on shares of Clarivate in a research report on Monday, April 17th. Wells Fargo & Company boosted their target price on shares of Clarivate from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Thursday, March 2nd. Morgan Stanley cut shares of Clarivate from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $11.00 to $12.00 in a research report on Monday, February 6th. Finally, Bank of America started coverage on shares of Clarivate in a research report on Wednesday, March 15th. They issued a “neutral” rating for the company. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $13.88.

Clarivate Price Performance

CLVT stock opened at $7.55 on Friday. The company has a 50 day simple moving average of $8.63 and a 200 day simple moving average of $9.47. Clarivate Plc has a 1 year low of $7.16 and a 1 year high of $15.10. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.88.

Clarivate (NYSE:CLVT – Get Rating) last released its quarterly earnings data on Wednesday, March 1st. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.07. The business had revenue of $675.30 million during the quarter, compared to analysts’ expectations of $651.42 million. Clarivate had a negative net margin of 151.76% and a positive return on equity of 8.39%. On average, analysts anticipate that Clarivate Plc will post 0.64 EPS for the current fiscal year.

Clarivate Company Profile

(Get Rating)

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Life Sciences and Healthcare (LS&H), and Intellectual Property (IP). The A&G segment consists of products and services to organizations that plan, fund, implement, and utilize education and research at a global, national, institutional, and individual level.